Treasury’s Lew: Stress in financial markets no cause for immediate concern

Treasury Secretary Jacob Lew is keeping a “careful eye on market volatility” and looking at any related risk to the U.S. economy, he said in a CNBC interview aired on Thursday morning. “We are looking at what, if any, risks there are, and so far have not seen the kinds of stresses in financial institutions that would cause us to have any immediate concerns,” he said in the interview. Lew also said he tries to “not respond immediately” to minute-to-minute or day-to-day market moves, but instead consults with senior leaders in the financial world, colleagues and central bankers. In the same interview, Lew also criticized China’s move last month to change its foreign-exchange policy.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Were You Correct? HGTV Magazine’s Latest High/Low Challenge

By Alyssa Sparacino

beaded-chandelier-high-low

The results are in! Were you able to correctly identify the “high” and “low” item in this pair of beaded chandeliers? These beaded chandeliers make for a casually elegant alternative to traditional, heavy glass chandeliers. On the left, each aqua bead was lacquered for a high-shine impact. Conversely, the fixture on the right features distressed beads that give it vintage appeal.

The winner of our HGTV Magazine prize package will be notified by email shortly. If you missed out this time on the HGTV Magazine giveaway, there will be another opportunity to win next month. For now, check out the latest high/low items on our shopping list, and let us know what you’ve been eyeing recently, too.

…read more

From:: HGTV

Geron shares jump after two positive drug studies

Geron Corp. shares jumped after the biotech company said the New England Journal of Medicine was going to publish two papers showing positive results for its drug imetelstat. Geron shares jumped 19% to $3.64. In two mid-stage clinical trials, Geron said the use of imetelstat suggested it works against malignant cells that cause essential thrombocythemia, a disease in which the body produces too many blood platelets, and against myelofibrosis, a bone marrow disease that disrupts the body’s production of blood cells.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Treasury’s Lew irked by the handling of China’s foreign-exchange devaluation

WASHINGTON (MarketWatch) – Treasury Secretary Jacob Lew on Wednesday criticized the way China announced last month’s shift in its foreign-exchange policy. In an excerpt of an interview aired on CNBC, Lew said that “there is an economic and political reality to things like exchange rates, and they need to understand that they signal their intentions by the actions they take and the way they announce them.” Markets were caught flat-footed last month when China loosened its grip on the yuan’s foreign exchange value which immediately weakened its currency versus the dollar. The potential ramifications of the move are still causing unease in global financial markets. Lew added that China needed to continue economic reforms designed to transform the economy from a dependence on exports towards more domestic spending and said the White House would continue to hold them accountable. Treasury’s admonishing of Beijing comes as President Obama is set to host China’s President Xi JinPing later this month. Lew and his Chinese counterpart will both attend the G-20 meetings in Turkey later this week.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Lannett shares jump on deal to acquire Kremers Urban Pharma

Lannett Co. shares jumped in the extended session Wednesday after the generic drug maker said it was acquiring Kremers Urban Pharmaceuticals Inc. for $1.23 billion. Lannett shares jumped 21% to $60. Kremers is the U.S. generic drug unit of UCB SA . Lannett said it expects the acquisition to boost fiscal 2016 EPS by mid- to high-single digits, and by 20% to 25% in fiscal 2017.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

LogMeIn names new CEO; co-founder Simon to remain chairman

LogMeIn Inc. said Wednesday its board of directors has named William “Bill” Wagner as the company’s new chief executive, replacing co-founder and longtime CEO Michael K. Simon. Simon will remain chairman of the board. Wagner, who joined the company in 2013, had been LogMeIn chief operating officer. Shares of the cloud computing company fell 1.8% in after-hours trading after rising 3.4% during the regular session.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Money Planning in 9 Steps

(TNS)—Everybody wants a solid financial plan, yet more than 40 percent of Americans don’t have one. Unless you develop a formal strategy, such as a written plan, you might well find any financial goal elusive. So, here are nine tips for planning: — Define your goals. Decide exactly what you need your finances to do […] …read more

From:: Finance and Economy